PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
82.32%
Net income growth above 1.5x MCHP's 10.56%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.24%
Negative yoy D&A while MCHP is 102.86%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-460.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
23.08%
Less working capital growth vs. MCHP's 194.56%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-42.86%
AR is negative yoy while MCHP is 195.88%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-135.09%
Negative yoy inventory while MCHP is 6867.72%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
85.25%
A yoy AP increase while MCHP is negative at -780.57%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
9.62%
Some yoy usage while MCHP is negative at -69.62%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-50.00%
Both negative yoy, with MCHP at -122.88%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
87.22%
Some CFO growth while MCHP is negative at -50.92%. John Neff would note a short-term liquidity lead over the competitor.
-15.48%
Both yoy lines negative, with MCHP at -54.39%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-248.32%
Both yoy lines negative, with MCHP at -1248.68%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
264.42%
Proceeds from sales/maturities above 1.5x MCHP's 51.43%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-638.89%
Both yoy lines negative, with MCHP at -54.98%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
1309.09%
We have mild expansions while MCHP is negative at -1321.02%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-24.45%
Negative yoy issuance while MCHP is 128.93%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-6.19%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.